The simian virus 40 small t (SV40ST) oncoprotein interacts with protein phosphatase 2A (PP2A), an abundantly expressed family of serine-threonine phosphatases. This interaction is essential for the transformation of human cells by SV40, and several PP2A subunits have been implicated as tumor suppressor genes. However, the pathways controlled by specific PP2A complexes involved in cell transformation remain incompletely understood. Using a comprehensive loss-of-function approach, we identified 4 PP2A regulatory subunits [B56a, B56g, PR72/PR130, and PTPA (protein phosphatase 2A activator)], which when suppressed replaced the expression of SV40ST in human cell transformation. We found that manipulation of complexes containing PP2A B56a, B56g, and PR72/PR130 activates the pathways regulated by c-Myc, Wnt, and PI3K (phosphoinositide 3-kinase)/Akt in a manner that depends on their specific phosphatase activity. In contrast, suppression of PTPA disrupts the assembly of PP2A heterotrimeric complexes, which leads to the activation of these same oncogenic pathways. These observations delineate the PP2A family members and pathways perturbed by SV40ST during human cell transformation. Cancer Res; 70(24); 10474-84. Ó2010 AACR.
Introduction
The aberrant activation of cellular signaling cascades contributes directly to human diseases. In particular, mutations that lead to constitutively active kinases are well-characterized drivers of cancer development, and small molecule kinase inhibitors are now used as primary therapy for particular cancers (1) . Moreover, inactivating mutations in phosphatases such as SHP2 contribute directly to malignant transformation. Although it is clear that phosphatases antagonize the action of kinases, the role of phosphatases in most human cancers remains undefined.
The study of transformation in human cell culture models has facilitated the identification of pathways related to cancer development. We previously showed that expression of the telomerase catalytic subunit (hTERT), the simian virus 40 early region (SV40 ER), and an oncogenic allele of H-RAS confers a tumorigenic phenotype to several types of human cells (2, 3) . The SV40 ER encodes 2 oncoproteins, the SV40 large T (SV40LT) and small t (SV40ST) antigens. SV40LT binds and inactivates the tumor suppressor proteins retinoblastoma and p53 (reviewed in ref. 3) .
SV40ST binds to and inhibits the activity of the serinethreonine protein phosphatase 2A (PP2A) family (4, 5) . Specifically, SV40ST mutants harboring amino acid substitutions that ablate the ability of SV40ST to bind PP2A also eliminate the ability of such mutants to transform rat and human cells (4, 6) . Conversely, an SV40ST mutant that contains only the PP2A-inactivation domain retains the ability to induce transformation (4) .
PP2A is also a major cellular binding partner for several other viral oncoproteins such as polyoma small and middle t antigens and the adenoviral E4orf4 protein (reviewed in ref. 7) , suggesting that like other targets of viral oncoproteins, PP2A plays a important role in tumor suppression. Indeed, inactivating alterations of PP2A subunits have been found in human cancers (8) (9) (10) (11) , and suppression of these same PP2A components contributes to cell transformation (12, 13) .
PP2A accounts for the majority of serine-threonine phosphatase activity in mammalian cells and has been implicated in the regulation of a wide diversity of signaling pathways (reviewed in ref. 7) . It refers to a family of phosphatases that contain a common catalytic C subunit, whose activity is regulated by a diverse set of regulatory proteins. PP2A complexes usually contain an active core dimer composed of a catalytic C subunit (PP2A C/PPP2 C) and a scaffolding A subunit (PR65/PPP2R1). In mammals, 2 distinct genes encode closely related versions of both the A and C subunits of PP2A. The AC dimer recruits a third regulatory B subunit that dictates the substrate specificity and localization of the PP2A heterotrimeric complex. Four unrelated families of B subunits have identified to date: B/B55/PR55/PPP2R2, B 0 /B56/ PR61/PPP2R5, B/PR72/PPP2R3, and Striatin (14) . At least 100 different PP2A heterotrimeric complexes are formed through combinatorial association of these subunits, and several lines of evidence suggest that particular PP2A holoenzyme complexes mediate specific physiologic functions.
The phosphotyrosine phosphatase (PTPase) activator (PTPA/PPP2R4) was initially described as a B regulatory subunit because of its ability to interact with the AC dimer. However, unlike other B subunits, which recruit the core enzyme to targeted PP2A substrates, PTPA may function as a chaperone that facilitates incorporation of divalent cations to the PP2A active site (15) .
The diversity of PP2A complexes suggests that dysfunction of several distinct PP2A complexes may affect specific pathways and, in turn, contribute independently to transformation. In consonance with this idea, recent structural studies revealed that SV40ST competes for the binding site on AC dimer with multiple regulatory B subunits (16) . We previously showed that suppression of the PP2A B56g subunit could partially replace SV40ST and induce cell transformation (17) . However, the degree of cell transformation induced by PP2A B56g suppression was quantitatively less than what we observed when we expressed SV40ST, suggesting that other PP2A subunits are involved in malignant transformation. Here we created and used a short hairpin RNA (shRNA) library targeting all known PP2A subunits to identify those subunits that are involved in human cell transformation.
Materials and Methods

Plasmids, cell lines, infections
pWZL-Blast c-Myc T58A was the gift of Dr. Rosalie Sears (Oregon Health and Sciences University). pBABE-puro b-catenin S33Y , pBabe-hygro dominant-negative TCF (dnTCF), and pBabe-GFP myr-Akt (mAkt) have been described (18, 19) . The pLKO.1-puro shGFP and pLKO.1-puro vectors containing shRNAs targeting specific PP2A subunits (Table 1) were provided by the RNAi Consortium (20) . Cells were cultured in minimal Eagle medium alpha supplemented with 10% heat-inactivated fetal calf serum (IFS). All transfections were conducted using Fugene 6 (Roche), and retroviral and lentiviral infections were carried out as described (20) . To generate stable cell lines, cells were selected using 2 mg/mL of puromycin for 3 days and 15 mg/mL of blastocidin for 10 days, or sorted using BD FACSAria cell sorter.
Immunoblotting and immunoprecipitation
Cells were suspended in a lysis buffer [50 mmol/L Tris-HCl, pH 7.5, 150 mmol/L NaCl, 1 mmol/L EDTA, protease inhibitor cocktail (Roche), and 0.5% NP-40] and cleared of insoluble material by centrifugation. Soluble proteins (100 mg) were subjected to SDS-PAGE followed by immunoblotting.
For immunoprecipitation, cells were lysed in a buffer containing 50 mmol/L Tris-HCl, pH 7.5, 150 mmol/L NaCl, 1mmol/L EDTA, protease inhibitor cocktail, and 0.3% CHAPS. Cell lysates (2 mg) were incubated with a PP2A C (BD Biosciences) antibody overnight at 4 C, followed by the addition of protein G Sepharose beads (Roche) overnight at 4 C. The beads were washed 3 times with lysis buffer and eluted with 2Â SDS sample buffer, followed by SDS-PAGE and immunoblotting.
The antibodies used included PP2A Aa (6F9) (Covance), PP2A C (BD Biosciences) and methyl-PP2A C (2A10; Santa Cruz Biotech), B56b (Santa Cruz Biotech), PR93 (S68; Cell Signaling), FLAG (M2; Sigma-Aldrich), b-actin (SigmaAldrich), HA (12C5; Boehringer Mannheim), active b-catenin (8E7) and total b-catenin (5H10; Millipore), polyclonal phospho-Akt (Ser473) and Akt1 (Cell Signaling), c-Myc (D84C12), and XP rabbit mAb (Cell Signaling). Affinity-purified polyclonal antibodies were raised against B55a, B56g, and SV40ST peptides as described (17) .
Quantitative RT-PCR
For RT-PCR, total RNA was isolated using RNeasy (Qiagen) and cDNA synthesis was done using the Advantage RT-PCR kit (Clontech). A list of primers used for quantitative RT-PCR (qRT-PCR) is presented in Supplementary Figure 2 . Real-time PCR reactions were conducted in an ABI Prism 7700 sequence detection system (Applied Biosystems), using SYBR green PCR master mix (Applied Biosystems).
Luciferase assays
Luciferase assays were done using the Dual luciferase system (Promega). One hundred nanograms of TOP-Glow or FOP-Glow luciferase vector was transfected in the presence of 5 ng of CMV-Wnt1 and 20 ng of CMV-Renilla, or 100 ng of pGL2-E2F2 was co-transfected with 20 ng of CMV-Renilla. The firefly luciferase activity was normalized to the Renilla luciferase activity.
Anchorage-independent growth and tumor formation
For soft agar assays, 10 5 cells were plated in triplicate into 0.4% Noble agar supplemented with 10% IFS. Four weeks after seeding, colonies were visualized and counted under microscope (magnification Â 10). For tumorigenicity assays, 2 Â 10 6 cells were injected subcutaneously into female BALB/ AnNTac-Foxn1 nu/nu immunodeficient mice (2) . The number of tumors formed was determined 40 days after injection.
Proliferation assays
A total of 1 Â 10 4 cells were plated in triplicate. The number of viable cells was determined using a Z2 particle count and size analyzer (Beckman-Coulter). For population doubling determinations, a seeding density of 1 Â 10 4 cells in a 10-cm plate was used, and triplicate plates were counted every 4 days.
Results
Identification of PP2A complexes involved in control of cell transformation
We and others previously found that SV40ST cooperates with SV40LT, hTERT, and H-Ras-V12 to transform a wide range of human cells (reviewed in ref.
3). The effect of SV40ST on cell transformation was only partially recapitulated by suppression of PP2A regulatory subunit B56g, suggesting that other PP2A regulatory subunits might also be involved in control of cell transformation. To determine whether other PP2A complexes are involved in cell transformation induced by SV40ST, we assessed the consequences of suppressing the PP2A catalytic subunits Ca and Cb in immortal, nontumorigenic HEK cells expressing SV40LT, hTERT, and H-Ras-V12 (HEK TER cells). By using several different shRNAs targeting PP2A Ca or Cb subunits, we generated stable cell lines expressing a range of expression of the Ca or Cb proteins. Suppression of the less abundant Cb subunit by 50% to 80% failed to change the proliferation rate of HEK TER cells and did not affect their ability to grow in anchorage-independent (AI) manner and to form tumors in immunodeficient mice ( Fig. 1A ; Supplementary Fig. 1 ). This observation suggests that inhibition of PP2A Cb-specific complexes do not contribute to transformation in this assay.
In contrast, HEK TER cells expressing very low levels of Ca proliferated poorly (Supplementary Fig. 1 ) and failed to grow in an AI manner or to form tumors in immunodeficient hosts (Fig. 1A ). This phenotype is consistent with prior reports that showed that deletion of Ca expression in yeast or mammalian cells leads to apoptosis (21, 22) . However, HEK TER cells in which we partially suppressed PP2A Ca (50%) exhibited the ability to form AI colonies and to form tumors similar to that observed after the introduction of SV40ST (Fig. 1A) . These observations are consistent with notion that inhibition of PP2A by SV40ST is necessary for SV40ER-mediated cell transformation (17) . We noted that HEK TER cells in which PP2A Ca was suppressed to 20% of wild-type levels showed an intermediate-transforming phenotype. The correlation between levels of PP2A suppression and the transforming phenotypes suggests that other PP2A complexes in addition to PP2A B56g-specific complexes contribute independently to cell transformation.
To identify PP2A regulatory B subunits in addition to B56g that are involved in cell transformation, we conducted a lossof-function screen by using lentivirally delivered shRNAs targeting each of the known PP2A regulatory subunits. We introduced 5 shRNAs targeting each of the known PP2A B subunits into HEK TER cells and determined the degree of gene suppression induced by each shRNA by qRT-PCR ( Fig. 1B; Supplementary Fig. 2 ) and by immunoblotting (Supplementary Fig. 3 ). Consistent with prior reports (23), we found that except for PP2A B55g and B55b subunits (which are mostly expressed in the brain), each of the PP2A B subunits is expressed in these cells. For each of the PP2A B subunits, we identified at least 2 different shRNAs that suppress each PP2A B subunit by at least 50% (Table 1) . We selected these 2 B subunit-specific shRNAs to create HEK TER cell lines that stably express each of these shRNAs to assess the consequences of suppressing each of these PP2A B subunits on AI growth.
We found that in addition to B56g, individually suppressing the expression of PR72/PR130, B56a, or PTPA permitted HEK TER cells to grow in an AI manner (Fig. 1B) . The expression of 2 distinct shRNAs specific to each of these B subunits results in statistically significant (P < 0.05) increases in AI colonies (Fig. 1B) . Because we used 2 shRNAs targeting different sequences in the same gene, it is unlikely that the observed effects are due to off-targets induced by these shRNAs. These observations implicate the PP2A regulatory subunits B56a, B56g, PR72/PR130, and PTPA in human cell transformation. 0 85% 89% 88% 69% 62% 73% 67% 80% 86% 70% 96% 82% 91% 82% 53% 50% 51% 61% 67% 87% 63% 84% 80% 95% (12, 17, (24) (25) (26) (27) , suggesting that they are involved in transformation induced by suppression of specific PP2A complexes. Thus, we analyzed activity of Akt, Wnt, and c-Myc pathways in HEK TER cells after suppression of specific PP2A subunits.
Consistent with previous reports (28-30), we found that expression of SV40ST and suppression of either PP2A Ca or B56g resulted in elevated levels of Akt phosphorylation (Ser473). We also observed a similar increase of phosphorylated Akt in cells in which we suppressed PTPA expression ( Fig. 2A) .
We also corroborated the observation that SV40ST overexpression or suppression of PP2A Ca resulted in increased expression of c-Myc protein and a small but reproducible increase in c-Myc-induced transactivation of the E2F2 promoter (31), which is dependent on the presence of c-Mycbinding sites (E-box elements; ref. 28) in the cells expressing SV40ST or in which PP2A Ca was suppressed (Fig. 2B) . We found that suppression of B56a, PR72/PR130, or PTPA led to a 2-fold increase in the steady-state levels of c-Myc protein (Fig. 2C) . In contrast, suppression of B56g was not accompanied with any change of c-Myc expression levels (Fig. 2C) .
Moreover, we observed an increase in levels of the dephosphorylated (Ser37 and Thr41), active form of b-catenin after overexpression of SV40ST or suppression of PP2A Ca (Fig. 3A) . HEK TER cells in which PP2A Ca was partially suppressed also showed increased TOP/FOP luciferase reporter activity as well as statistically significant increased expression of b-catenin-driven genes, such as CCDN1 and AXIN (Fig. 3B) . As previously reported (27) suppression of PP2A B56g induced b-catenin-dependent transcription (Fig. 3C) . Suppression of PTPA also induced TOP/FOP luciferase reporter activity. In contrast, we observed a decrease in b-catenin activity after suppression of PR72/130 (Fig. 3C ). These observations indicate that suppression of specific PP2A complexes resulted in upregulation of the cancerrelated signaling pathways PI3K/Akt, Wnt, and c-Myc. Depletion of specific PP2A B regulatory subunits resulted in activation of a subset of these signaling pathways, whereas inhibition of both PP2A Ca and PTPA resulted in activation of all 3 pathways. Consistent with these observations, we found that suppression of B56a, B56g, or PR72/PR130 resulted in a small decrease in PP2A-associated phosphatase activity, whereas depletion of both PP2A Ca and PTPA inhibited PP2A phosphatase activity more dramatically ( Supplementary  Fig. 4) .
Manipulation of Akt, b-catenin, and c-Myc substitutes for SV40ST to induce transformation
To study whether regulation of Akt, b-catenin, and c-Myc activity by specific PP2A complexes contributes to SV40ST-mediated transformation, we used both loss-of-function and gain-of-function approaches. Specifically, we suppressed the expression of Akt, b-catenin, and c-Myc in HEK TER cell transformed by SV40ST (HEK TERST cells). We found that partial suppression of Akt, c-Myc, or b-catenin by specific shRNAs did not significantly affect proliferation (Supplementary Fig. 5 ) but did result in approximately 30% fewer AI colonies in cells dependent on SV40ST for transformation (Fig. 4A) . Moreover, overexpression of a dominantly interfering TCF mutant (dnTCF) partially inhibited the ability of HEK TERST cells to grow in AI manner (Fig. 4A) . The suppression of the SV40ST-transforming phenotype after inhibition of PI3K/ Akt, c-Myc, or Wnt signaling pathways confirmed that these (Fig. 4B) . We found that HEK TER expressing the stabilized and therefore activated mutants of b-catenin, Akt, or c-Myc formed few AI colonies. Coexpression of activated Akt and b-catenin resulted in increased cell proliferation and an enhanced capacity to grow in AI fashion but did not allow such cells to form tumors in immunodeficient mice (Supplementary Fig. 6; Fig. 4C ).
In contrast, the stabilized c-Myc T58A mutant cooperated with activated Akt and b-catenin to increase cell proliferation to the same level as was found when we expressed SV40ST (Supplementary Fig. 6 ). Coexpression of c-Myc T58A with myristoylated Akt and b-catenin S33Y conferred the ability to grow in an AI manner (Fig. 4C) . Indeed, we observed that both the size and number of AI colonies were similar to that observed for SV40ST-expressing cells (Supplementary Fig. 7) . Moreover, perturbation of all of these pathways was necessary to induce the formation of tumors in immunodeficient mice (Fig. 4C) . These observations show that simultaneously activating the PI3K/Akt, b-catenin, and c-Myc pathways cooperate to induce tumor formation similar to what we observed when PP2A Aa was suppressed. 
Colony number
Suppression of PTPA induces cell transformation through dysregulation of PP2A holoenzyme assembly
We assessed the consequences of suppressing the PP2A catalytic subunits Ca and Cb on the composition of PP2A complexes in HEK TER cells. Suppression of PP2A Ca resulted in a substantial reduction of the steady-state levels of the PP2A B55a, B56b, B56g, and PR93 regulatory subunits and the PP2A A subunits (Fig. 5A ). These observations corroborate prior work that showed that the PP2A regulatory and structural subunits exhibit limited stability when not bound to a catalytic PP2A C subunit (12, 35) , and suggest that the loss of PP2A Ca induces cell transformation through disruption of multiple heterotrimeric PP2A complexes.
In contrast, suppressing the expression of the PP2A Cb subunit resulted in only a small decrease of the steady-state levels of these PP2A subunits (Fig. 5A) , confirming that PP2A complexes containing Cb represent a minor fraction of the total PP2A complexes in the cells (36, 37) .
Previous reports revealed that Rrd1 and Rrd2, the PTPA orthologues in yeast, affect the methylation of the PP2A catalytic subunit and control the formation of PP2A heterotrimeric complexes (15, 38) . Specifically, deletion of Rrd1 reduces yeast PP2A stability and alters its substrate specificity (15, 38) . Mammalian PTPA can complement a mutant of the yeast PTPA genes Rrd1 and Rrd2, suggesting that the mammalian and yeast PTPA orthologues share functional domains (15) . When we analyzed cells in which we had suppressed PTPA expression, we found that the loss of PTPA dramatically abolished methylation of PP2A catalytic subunit. Because methylation of PP2A C could also be affected by its phosphorylation at Y307, we tested whether PTPA affects PP2A C phosphorylation and found no change in PP2A C phosphorylation in cells in which PTPA expression was suppressed ( Supplementary Fig. 8 ). In contrast, we observed a diminished ability of PP2A C to bind to the PP2A A subunit (Fig. 5B) and found decreased PP2A A structural subunit expression in cells in which PTPA expression was suppressed ( Supplementary  Fig. 8) , consistent with the notion that PP2A A subunits are unstable when not bound to the PP2A C subunit. These observations suggest that PTPA suppression affects the formation of heterotrimeric PP2A complexes.
Specifically, these observations suggest that suppression of PTPA induces cell transformation through the regulation of PP2A C methylation. To test whether methylation of PP2A C affected the tumor-suppressive properties of PP2A, we generated a methylation-deficient DL309 PP2A Ca mutant (5). We also tested phosphorylation site mutants of PP2A Ca (T304A, T304D, Y307A, and Y307F), which have been shown to affect PP2A methylation. Specifically, the PP2A Ca phosphorylationdeficient (T304A and Y307F) and phosphorylation-mimicking (T304D) mutants have been found to be methylated, whereas the PP2A Ca phosphorylation-mimicking (Y307D) mutants fail to exhibit methylation (39, 40) . We introduced the wild-type or mutant PP2A Ca into HEK TER cells in which we had suppressed the endogenous PP2A Ca and analyzed AI growth of these cell lines. We found that wild-type PP2A Ca and the T304A, Y307F, and T304D mutants suppressed the transforming phenotype induced by partial suppression of PP2A Ca. In contrast, expression of the PP2A Ca methylation-deficient DL309 or Y307D mutants failed to inhibit the transformed phenotype (Fig. 5C ). These results suggest that the methylation of PP2A Ca is crucial for tumorsuppressive properties of PP2A and that PTPA subunit contributes to control of cell transformation through regulating the methylation status of PP2A C.
Discussion
DNA tumor viruses express dominant acting oncoproteins that exert their effects by binding to and deregulating cellular targets. In nearly all cases, the targets of viral oncoproteins have been subsequently shown to play important roles in spontaneously arising human cancers. Although PP2A is the primary host-binding partner of SV40ST, the biochemical complexity of the PP2A family and the multitude of signaling pathways regulated by this abundant family of phosphatases have complicated efforts to establish the molecular mechanisms employed by SV40ST to induce cell transformation.
Prior work showed that SV40ST displaces multiple PP2A regulatory B subunits from the AC core dimer (16, 17, 41) , suggesting that more than 1 PP2A specific complexes is involved in cell transformation. Indeed, we found that partial suppression of the PP2A Ca catalytic subunit is accompanied by the degradation of multiple PP2A subunits and nearly completely recapitulates the transformation phenotype induced by the expression of SV40ST. Moreover, a number of other reports have shown that perturbation of several distinct PP2A complexes leads to the same phenotype. As an example, at least 3 different regulatory PP2A subunits, B56g, PR72, and PR130, are involved in regulation of the different components of the Wnt signaling pathway (25) (26) (27) .
In addition, other PP2A subunits may contribute to cell transformation in a manner that is distinct from that induced by SV40ST. For example, we found that depletion of the PP2A Ab structural subunit induced transformation through activation of the small GTPase RalA. Because SV40ST cannot bind PP2A Ab-specific complexes, this mechanism of PP2A-mediated transformation is SV40ST independent (13).
Here we have identified several PP2A-specific complexes involved in control of cell transformation. Suppression of at least 3 different B subunits, B56a, B56g, and PR72/130, as well as PTPA, induced a transformed phenotype, suggesting that these specific regulatory subunits contribute to cell transformation. Consistent with this idea, these same subunits have been implicated in the regulation of PI3K/Akt, Wnt, and c-Myc signaling. Specifically, PP2A holoenzymes containing the B56a regulatory subunit associate with and directly dephosphorylate c-Myc at Ser62, a residue previously implicated in targeting c-Myc to proteosome degradation (28, 32, 42) . Moreover, loss of B56a or PR72/PR130 expression results in c-Myc overexpression, elevated levels of c-Myc Ser62 phosphorylation, and increased c-Myc function (24) .
We note that overexpression of the c-Myc T58A mutant has been reported to replace SV40ST in cell transformation (28) . We (43) and others (44) have reported that the combination of expressing hTERT and extended propagation of cells in culture led to amplifications of endogenous c-Myc. Herein, we used highly efficient retroviral infections to create cell lines and did not use cells that had been in culture for more than 30 population doublings.
Loss of B56g has been shown to activate the Akt pathway; however, it remains unclear whether Akt1 is a direct target of the PP2A B56g-specific complex (17, 45) . B56g may also contribute to the regulation of Wnt pathway through regulation of APC. By binding to APC, PP2A B56g inhibits formation of APC-Axin complexes leading to destabilization of b-catenin (27) . As a result, overexpression of B56g reduces the abundance of b-catenin and inhibits transcription of b-catenin target genes (27) .
The PR72 and PR130 isoforms, which share the same C terminus, have been shown to regulate activity of Naked cuticle, which is a Wnt antagonist. PR72 acts as a negative regulator of the Wnt signaling cascade through its interaction with Naked cuticle. On the other hand, PR130 modulates Wnt signal transduction by restricting the ability of Naked cuticle to function as a Wnt inhibitor (25, 26) . As previously reported (46), we found that PR130 isoform is expressed at much higher levels than PR72 in HEK TER cells and shRNAs specific for PR72/PR130 subunit disproportionally affected the expression of PR130 isoform (data not shown). Specifically, we used 2 independent shRNAs targeting PR72/130 subunit, of which shPR72/130-1 targets a sequence present only in PR130 isoform whereas shPR72/130-2 targets both PR72 and PR130. Because both shRNAs induced the same phenotypes, the observed results were specific for the PR130 isoform.
In contrast to the other PP2A regulatory B subunits identified in our screen, PTPA disrupts PP2A function through a distinct mechanism. The recent elucidation of the PP2A holoenzyme structure showed that the highly conserved Cterminal tail of the PP2A C subunit resides at a critical interface between the PP2A A structural subunit and the B subunit B56g (14) . As such, the recruitment of a B subunit to the core enzyme is tightly regulated by the methylation and phosphorylation patterns of the C-terminal tail. The formation of the holoenzyme complex and the activation of PP2A C are also restrained by a series of interlocking steps involving the dual action of the phosphatase methylesterase PME-1 and PTPA. The mechanism by which PTPA induces C subunit activity remains to be determined, but the PP2A A-PTPA complex may function partly by inhibiting the methylesterase activity of PME-1 (47) . Consistent with this notion, we found that suppression of PTPA resulted in a marked decrease in PP2A C methylation.
We found that methylation of PP2A C is crucial for PP2A tumor-suppressive activity. The highly conserved C-terminal 304 TPDYFL 309 tail of PP2A C is also phosphorylated at Y307 and T304, and phosphorylation of these residues affects the methylation of PP2A Ca (39, 40) . Indeed, the methylationdeficient DL309 and Y307D PP2A Ca mutants failed to reverse the tumorigenic phenotype induced by PP2A Ca suppression. This finding is consistent with the observation that phosphorylation at Y307 dramatically inhibits PP2A activity (48) . PTPA suppression induced the strongest transforming phenotype among the B subunits tested in our screen, and overexpression of mouse PTPA induces apoptosis in HCT116 colon carcinoma cells (49) . These observations implicate PTPA as a potential tumor suppressor that acts by modulating the assembly of PP2A heterotrimers through methylation of PP2A catalytic subunit. Indeed, a recent report showed that suppression of the PP2A methylesterase PME-1 affects both cell proliferation and AI growth and overexpression of PME-1 correlated with the stage of disease in gliomas (50) .
As previously reported (7), we found that PP2A is implicated in the regulation of a number of major signaling pathways, including Wnt, PI3K/Akt, and c-Myc. However, we note that direct substrates that modulate these signaling pathways have yet to be identified for the specific PP2A complexes. Further studies are necessary to dissect the mechanisms by which specific PP2A complexes affect these oncogenic pathways. However, the systematic identification of PP2A B subunits involved in control of cell transformation defines the PP2A-dependent pathways regulated by SV40ST and provides insight into how such pathways are perturbed in cell transformation.
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